Last updated on December 2018

A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)


Brief description of study

The main purpose of this study is to evaluate the safety and efficacy of tadalafil in pediatric participants with pulmonary arterial hypertension. Participants will receive study treatment for 6 months in the double-blind period (Period 1), and then will be eligible to enroll into an open-label 2 year extension period (Period 2) during which participants will receive tadalafil.

Clinical Study Identifier: NCT01824290

Contact Investigators or Research Sites near you

Start Over

Masaru Miura

Tokyo Metropolitan Children's Medical Center
Fuchu, Japan
1.28miles
  Connect »

Hiroshi Ono

National Center For Child Health And Development
Setagaya-ku, Japan
9.88miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.